Trevi Therapeutics
TRVI
TRVI
19 hedge funds and large institutions have $35.6M invested in Trevi Therapeutics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.83% less ownership
Funds ownership: 70.77% → 65.94% (-4.8%)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$260K | |
| 2 | +$72.9K | |
| 3 | +$29K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$26.2K |
| 5 |
BlackRock
New York
|
+$25.1K |
Top Sellers
| 1 | -$36K | |
| 2 | -$36K | |
| 3 | -$9.68K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2K |
| 5 |
First Manhattan
New York
|
-$263 |